-32%

est. 2Y upside i

AI & MLSeries A

Video AI to automatically detect and respond to production line…

Rank

#3987

Sector

Industrial AI & Automation

Est. Liquidity

~5Y

Data Quality

Data: Low

Cerrion is a high-risk equity bet at this stage.

Last updated: May 5, 2026

Bull (12%)+150%

Cerrion deploys its $18M Series A aggressively into enterprise GTM, accelerating ARR from $1.8M to $7–8M by end-2027 at 100%+ YoY; a Series B priced at $175–200M valuation delivers roughly +150% upside from the estimated ~$80M entry. This requires winning enterprise volume beyond the current Unilever/Pfizer-supplier tier and executing a near-10x growth inflection.

Base (50%)-40%

Growth improves modestly from 9% to 20–25% YoY as the Series A capital slowly matures GTM; revenue reaches ~$3–3.5M ARR by end-2027, but below-benchmark momentum compresses multiples to 10–12x for industrial SaaS, implying a ~$35–42M valuation — roughly -40% to -55% from the estimated $80M entry. A likely Series B further dilutes common stock before any liquidity event.

Bear (38%)-80%

Growth stalls at or below current 9% YoY; Cerrion burns through $28M total funding without reaching profitability or Series B-quality metrics, culminating in a distressed bridge or acqui-hire at $8–15M — an -80% to -90% loss from estimated entry. Incumbent Siemens/Rockwell bundling and hyperscaler AI platforms accelerate churn in the SME manufacturing segment.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

35%

$28M total funding against an estimated ~$80M post-money Series A valuation produces a ~35% preference ratio, meaning preferred shareholders absorb the first $28M of any exit before common stock participates at all.

Dilution Risk

high

At $1.8M ARR, Cerrion will almost certainly require at least one more significant financing round (Series B likely $30–50M) before any liquidity event, implying 20–30%+ additional dilution to current common holders.

Secondary Liquidity

none

No secondary market activity is expected at this early stage; employees are effectively illiquid until an IPO or acquisition, realistically 4–7 years out.

Questions to Ask at the Interview

Strategic questions based on Cerrion's data — designed to show you've done your homework.

  • 1

    “What is the current ARR run rate as of Q1 2026, and what pipeline metrics or bookings data indicate the $18M Series A is already driving a growth inflection beyond the 9% YoY rate seen in December 2025?”

  • 2

    “What is the average contract value (ACV) per production line deployment and typical enterprise sales cycle — and how do your pre-built industry-specific video agents compress that cycle versus a custom solution from Siemens or Rockwell?”

  • 3

    “What ARR milestone triggers the Series B raise, what is your anticipated timeline, and how does the employee option pool refresh work relative to the dilution that round will introduce?”

Community

Valuation Sentiment

Our model estimates -32% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.